Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and SCAN domain containing 4 (ZSCAN4) is a transcription factor that plays a pivotal role in maintaining telomere length and genomic stability during early embryonic development and in pluripotent stem cells (Zalzman et al., 2010, Nature). Unlike the telomerase-dependent pathway, ZSCAN4 facilitates telomere elongation through a recombination-mediated mechanism, which is essential for the long-term survival and karyotype stability of embryonic stem cells (Amano et al., 2013, Nature Communications). In the context of regenerative medicine, ZSCAN4 is being utilized as a therapeutic agent to rejuvenate hematopoietic stem cells (HSCs) in patients with telomere biology disorders such as Dyskeratosis congenita and aplastic anemia (Ko et al., 2016, Stem Cells). By employing a temperature-sensitive Sendai virus (SeV) vector for ex vivo transduction, ZSCAN4 can be transiently expressed in CD34+ cells without the risk of permanent genomic integration, as SeV replicates exclusively in the cytoplasm (Nakanishi & Iida, 2012, Journal of Controlled Release). This transient pulse of ZSCAN4 expression leads to rapid telomere extension and enhances the functional fitness of the stem cell pool (Nishinosono et al., 2019, Scientific Reports). This approach represents a novel gene therapy strategy aimed at restoring hematopoiesis by addressing the underlying molecular defect of stem cell exhaustion.
Transient expression of the ZSCAN4 protein to induce rapid telomere elongation through a recombination-based mechanism (ALT-like), thereby restoring the proliferative capacity and genomic integrity of hematopoietic stem cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and SCAN domain containing 4 (ZSCAN4).